Omega Funds

Omega Funds

Omega Funds

Omega Funds global life sciences-based investment firm specialized in direct secondary transactions.
Follow us
Alexa global traffic share
Latest investments Show all
$91,000,000
Post-IPO equity
Alpine Immune Sciences
$62,000,000
Venture capital (Series A)
Endeavor
Team Size
1–10
Employees
Geographical Focus
Markets focus
Past year's investments

Omega Funds participated in fewer than 3 rounds over the past year

Latest rounds
  • Alpine Immune Sciences: Post-IPO equity ($91M)
  • Endeavor: Venture capital (Series A) ($62M)
  • eTheRNA Immunotherapies: Venture capital (Series B) (€34M)